Let's talk medical research

Connecting patients with clinical research opportunities is our mission here at Antidote, but often, we find that misconceptions can serve as ...

Antidote’s podcast, Talk of the Towne, hosted by Antidote’s Senior Clinical Informatics Manager, Dr. Richard Towne, is an interview series featuring ...

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that results in weakened breathing and reduced lung function. In the U.S., it is ...

We are excited to announce that we have received the Silver Award from EcoVadis for the second year in a row. EcoVadis is the world’s largest, most ...

In the third quarter of 2018, we conducted a survey with SCORR Marketing to learn more about the patient perception of clinical trial participation. ...

Alzheimer’s disease, the most prevalent type of dementia, is diagnosed in more than 6 million Americans. Estimates project that by 2050, 13 million ...

Globally, there are thousands of research studies and clinical trials conducted each year, all with the shared goal of bringing new treatment options ...

Today, Antidote is excited to announce our collaboration with Beyond Type 1 and JDRF to release the first-ever Spanish-language clinical trial search ...

As part of our efforts to better understand patients and their motivations to participate in clinical trials, Antidote and SCORR Marketing partnered ...

With over 2 billion daily active users, Facebook has one of the widest reaches on the internet today — especially for those trying to reach patients ...